NCT06531135

Brief Summary

To test the effects of a 10-wk stress management interventions vs. a 5-wk control condition on positive psychosocial adaptation in women being treated for breast cancer. Participants assigned to either of the stress management groups will show better positive psychosocial adaptation compared to those in the control group.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Nov 2021Dec 2026

Study Start

First participant enrolled

November 23, 2021

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

4.1 years

First QC Date

July 28, 2024

Last Update Submit

July 28, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • posttraumatic growth by the PTGI

    the PTGI a 21-item questionnaire each scored on a range of 0-5.

    Baseline (T1), post-intervention (T2), 6 months post-intervention (T3)

  • Distress by the HADS

    The HADS is a 14-item scale, with seven items relating to anxiety and seven relating to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 and 21 for either anxiety or depression.

    Baseline (T1), post-intervention (T2), 6 months post-intervention (T3)

Secondary Outcomes (3)

  • Positive and Negative affect

    Baseline (T1), post-intervention (T2), 6 months post-intervention (T3)

  • Perceived Stress Management Abilities

    Baseline (T1), post-intervention (T2), 6 months post-intervention (T3)

  • Quality of Life by the SF-36

    Baseline (T1), post-intervention (T2), 6 months post-intervention (T3)

Study Arms (2)

stress management

EXPERIMENTAL

10 weeks of group intervention of Taiwanese version stress management intervention.

Behavioral: T-CBSM

Support group

ACTIVE COMPARATOR

5 weeks of supportive group intervention.

Behavioral: Support group

Interventions

T-CBSMBEHAVIORAL

A 10-week remotely-delivered group, lasting about 120 minutes each session.

Also known as: stress management
stress management
Support groupBEHAVIORAL

Participants will receive weekly supportive-expressive group intervention for two hours per week for five weeks total.

Also known as: Supportive-Expressive Group
Support group

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 20 and 70 years
  • Newly diagnosed breast cancer patients in stages I, II, or III (with no prior history of cancer)
  • Literate, without significant cognitive impairments
  • Capable of writing and expressing themselves in Chinese

You may not qualify if:

  • Major psychiatric disorders (such as schizophrenia), personality disorders, and substance addiction (excluding smoking)
  • Currently participating in other breast cancer-related psychotherapy studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Koo Foundation Sun Yat-Sen Cancer Center

Taipei, 11259, Taiwan

Location

MeSH Terms

Interventions

Self-Help Groups

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Study Officials

  • Ashley Wei TIng Wang

    Soochow University ITaipei)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Psychiatric department, KFSYSCC, Taiwan

Study Record Dates

First Submitted

July 28, 2024

First Posted

July 31, 2024

Study Start

November 23, 2021

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

July 31, 2024

Record last verified: 2024-07

Locations